These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7145769)

  • 21. Noncontraceptive estrogens and abnormalities of endometrial proliferation.
    Weiss NS
    Ann Intern Med; 1978 Mar; 88(3):410-2. PubMed ID: 629503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endometrial carcinoma following estrogen-progestogen therapy in Turner's syndrome: a case report and review of the literature.
    Krishnamurthy S; Adcock LL; Okagaki T
    Gynecol Oncol; 1977 Sep; 5(3):291-8. PubMed ID: 332603
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effective progestogen therapy of endometrial hyperplasia and adenocarcinoma by administration of a combined progestogen-estrogen preparation].
    Miyawaki Y; Ueki M; Sugimoto O
    Nihon Gan Chiryo Gakkai Shi; 1988 Oct; 23(10):2598-605. PubMed ID: 3209928
    [No Abstract]   [Full Text] [Related]  

  • 24. Estrogen regimen of women with endometrial carcinoma. A retrospective case-control study at Radiumhemmet.
    Obrink A; Bunne G; Collén J; Tjernberg B
    Acta Obstet Gynecol Scand; 1981; 60(2):191-7. PubMed ID: 7246086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carcinoma of the endometrium.
    Cavanagh D; Marsden DE; Ruffolo EH
    Obstet Gynecol Annu; 1984; 13():211-60. PubMed ID: 6371616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen use and endometrial cancer.
    Studd JW; Thom M
    N Engl J Med; 1979 Apr; 300(16):922-3. PubMed ID: 423943
    [No Abstract]   [Full Text] [Related]  

  • 27. Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus. Pathology review and analysis of prognostic variables.
    Hendrickson M; Ross J; Eifel PJ; Cox RS; Martinez A; Kempson R
    Gynecol Oncol; 1982 Jun; 13(3):373-92. PubMed ID: 6284595
    [No Abstract]   [Full Text] [Related]  

  • 28. Estrogen and endometrial carcinoma. An independent pathology review supporting original risk estimate.
    Gordon J; Reagan JW; Finkle WD; Ziel HK
    N Engl J Med; 1977 Sep; 297(11):570-1. PubMed ID: 196195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogens and endometrial cancer.
    Ziel HK
    J Reprod Med; 1977 Dec; 19(6):364. PubMed ID: 592312
    [No Abstract]   [Full Text] [Related]  

  • 30. Defining the pathology of endometrial hyperplasia, dysplasia and carcinoma.
    Sommers SC
    Pathol Res Pract; 1982 Aug; 174(3):175-97. PubMed ID: 6292884
    [No Abstract]   [Full Text] [Related]  

  • 31. Cytologic findings in endometrial hyperplasia.
    Kashimura M; Baba S; Shinohara M; Kashimura Y; Saito T; Hachisuga T
    Acta Cytol; 1988; 32(3):335-40. PubMed ID: 3376700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endometrial pathology and its relation to estrogen therapy in patients with hypogonadism.
    Rosenwaks Z; Urban MD; Wentz AC; Lee PA; Parmley TH; Migeon CJ; Jones GS; Woodruff JD
    Pediatrics; 1978 Dec; 62(6 Pt 2):1184-8. PubMed ID: 724357
    [No Abstract]   [Full Text] [Related]  

  • 33. Squamous differentiation and basal lamina deposition in endometrial adenoacanthoma.
    Gould VE; Sommers SC; Terzakis JA
    Am J Pathol; 1976 Jul; 84(1):25-38. PubMed ID: 945698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Atypical hyperplasia of theendometrium and cancer of the uterine body].
    Makaveeva V
    Akush Ginekol (Sofiia); 1970; 9(4):324-7. PubMed ID: 5504593
    [No Abstract]   [Full Text] [Related]  

  • 35. Detection of endometrial carcinoma and hyperplasia in asymptomatic women.
    Koss LG; Schreiber K; Oberlander SG; Moussouris HF; Lesser M
    Obstet Gynecol; 1984 Jul; 64(1):1-11. PubMed ID: 6738931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The aetiology and pathology of endometrial cancer.
    Fox H
    Clin Obstet Gynaecol; 1976 Aug; 3(2):371-87. PubMed ID: 1009726
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of the progestogen challenge test to reduce the risk of endometrial cancer.
    Gambrell RD; Massey FM; Castaneda TA; Ugenas AJ; Ricci CA; Wright JM
    Obstet Gynecol; 1980 Jun; 55(6):732-8. PubMed ID: 6446050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Detection and diagnosis of atypical hyperplasia and adenocarcinoma of the endometrium using cytology].
    Nollomont-Lambert JC; Lambotte R
    J Gynecol Obstet Biol Reprod (Paris); 1988; 17(6):733-6. PubMed ID: 3209834
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hyperplasia and adenocarcinoma of the endometrium: morphologic and immunohistochemical aspects].
    Charpin C; Toga M
    J Gynecol Obstet Biol Reprod (Paris); 1988; 17(6):719-27. PubMed ID: 3062072
    [No Abstract]   [Full Text] [Related]  

  • 40. Endometrial response to estrogen and progesterone therapy in patients with gonadal dysgenesis.
    Benjamin I; Block RE
    Obstet Gynecol; 1977 Aug; 50(2):136-8. PubMed ID: 876552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.